Perrigo Company plc Stock

Equities

PRGO

IE00BGH1M568

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
27.53 USD +0.86% Intraday chart for Perrigo Company plc -1.26% -14.45%
Sales 2024 * 4.62B Sales 2025 * 4.83B Capitalization 3.75B
Net income 2024 * -74M Net income 2025 * 106M EV / Sales 2024 * 1.51 x
Net Debt 2024 * 3.21B Net Debt 2025 * 3.01B EV / Sales 2025 * 1.4 x
P/E ratio 2024 *
-19 x
P/E ratio 2025 *
172 x
Employees 9,140
Yield 2024 *
4%
Yield 2025 *
4.26%
Free-Float 99.66%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.86%
1 week-1.26%
1 month-15.71%
3 months+4.84%
6 months-9.62%
Current year-14.45%
More quotes
1 week
26.85
Extreme 26.85
28.14
1 month
26.85
Extreme 26.85
33.46
Current year
25.77
Extreme 25.77
34.60
1 year
25.77
Extreme 25.77
40.28
3 years
25.77
Extreme 25.77
50.90
5 years
25.77
Extreme 25.77
63.86
10 years
25.77
Extreme 25.77
215.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 23-06-29
Director of Finance/CFO 49 22-05-15
Chief Tech/Sci/R&D Officer - 14-12-31
Members of the board TitleAgeSince
Chairman 55 20-12-14
Director/Board Member 68 17-02-05
Director/Board Member 67 17-02-05
More insiders
Date Price Change Volume
24-05-31 27.53 -0.15% 1,752,160
24-05-30 27.57 +1.36% 2,308,712
24-05-29 27.2 -0.48% 1,555,073
24-05-28 27.33 -1.97% 1,178,200
24-05-24 27.88 -0.85% 1,808,496

Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT

More quotes
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.53 USD
Average target price
39.5 USD
Spread / Average Target
+43.48%
Consensus